1. Adamyan LV, Andreeva EN, Apolikhina IA, Artymuk NV, Ashrafyan LA, Balan VE, Ermakova EI, Kuznetsov SYu, Rodionov VV, Smetnik AA, Filippov OS, Chernukha GE, Yureneva SV, Yarmolinskaya MI, Yakushevsaya OV. Menopause and climacteric state in women. Clinical guidelines. 2021. (In Russ.)
2. Kovaleva YuV. Adipose tissue hormones and their role in the formation of hormonal status in the pathogenesis of metabolic disorders in women. Arterial’naya gipertensiya. 2015;21:4:356-370. (In Russ.)
3. Urudzheva NG, Esedova AE, Allakhkulieva SZ, Idrisova MA, Gadzhieva AM. Features of the clinical course of metabolic syndrome in postmenopausal patients. Akusherstvo i ginekologiya. 2020;4:(application):210-211. (In Russ.)
4. Kuznetzov MR, Papysheva OV. Menopausal hormone therapy and vascular events: what is the relationship? Doctor.Ru. 2018;10:51-55. (In Russ.)
5. Poryvkina ON, Adasheva TV, Zadionchenko VS. Efficiency and safety of hormone replacement therapy in postmenopausal patients with metabolic syndrome. Kardiovaskulyarnaya terapiya i profilaktika. 2009;8:75-80. (In Russ.)